臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"ann lii cheng"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 231-280 / 690 (共14页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2021-09-01T01:54:21Z	Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method - Analysis of 2010 Taiwanese patients	Chen C.-H.; Hu F.-C.; Huang G.-T.; Lee P.-H.; Tsang Y.-M.; ANN-LII CHENG; Chen D.-S.; Wang J.-D.; Sheu J.-C.
臺大學術典藏	2021-09-01T01:54:21Z	Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia	Lin C.-H.; Liau J.-Y.; Lu Y.-S.; Huang C.-S.; Lee W.-C.; Kuo K.-T.; Shen Y.-C.; Kuo S.-H.; Lan C.; Liu J.M.; Kuo W.-H.; Chang K.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:20Z	Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study	Faivre S.; Raymond E.; Boucher E.; Douillard J.; Lim H.Y.; Kim J.S.; Zappa M.; Lanzalone S.; Lin X.; DePrimo S.; Harmon C.; Ruiz-Garcia A.; Lechuga M.J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:20Z	Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma	Yang S.-H.; Lin Z.-Z.; Kuo S.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:20Z	Lamivudine and hepatitis B reactivation	Hsu C.; ANN-LII CHENG; Chen P.-J.
臺大學術典藏	2021-09-01T01:54:19Z	Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer	Lin C.-C.; Hsu C.-H.; Cheng J.C.; Huang C.-Y.; Tsai Y.-C.; Hsu F.-M.; Huang K.-H.; ANN-LII CHENG; Pu Y.-S.
臺大學術典藏	2021-09-01T01:54:19Z	Sorafenib for the treatment of hepatocellular carcinoma across geographic regions	Hsu C.; Shen Y.-C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:19Z	Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma	Ou D.-L.; Shen Y.-C.; Liang J.-D.; Liou J.-Y.; Yu S.-L.; Fan H.-H.; Wang D.-S.; Lu Y.-S.; Hsu C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:19Z	Clinicopathologic features and treatment outcome of non-Hodgkin lymphoma of the breast - A review of 42 primary and secondary cases in Taiwanese patients	Lin Y.-C.; Tsai C.-H.; Wu J.-S.; Huang C.-S.; Kuo S.-H.; Lin C.-W.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:18Z	Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy	Lin C.-H.; Lien H.-C.; Hu F.-C.; Lu Y.-S.; Kuo S.-H.; Wu L.-C.; You S.-L.; ANN-LII CHENG; Chang K.-J.; Huang C.-S.
臺大學術典藏	2021-09-01T01:54:18Z	Synergistic Effect of Radiation and Interleukin-6 on Hepatitis B Virus Reactivation in Liver Through STAT3 Signaling Pathway	Chou C.H.; Chen P.-J.; Jeng Y.-M.; ANN-LII CHENG; Huang L.-R.; Cheng J.C.-H.
臺大學術典藏	2021-09-01T01:54:18Z	Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer	Ch'ang H.-J.; Huang C.-L.; Wang H.-P.; Shiah H.-S.; Chang M.-C.; Jan C.-M.; Chen J.-S.; Tien Y.-W.; Hwang T.-L.; Lin J.-T.; ANN-LII CHENG; Whang-Peng J.; Chen L.-T.
臺大學術典藏	2021-09-01T01:54:18Z	Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design	Hsu C.; Shen Y.-C.; Cheng C.-C.; Hu F.-C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:17Z	Molecular targeted therapy for advanced hepatocellular carcinoma: Current status and future perspectives	Shen Y.-C.; Hsu C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:17Z	Characteristics and risk factors of oxaliplatin-related hypersensitivity reactions	Shao Y.-Y.; Hu F.-C.; Liang J.-T.; Chiu W.-T.; ANN-LII CHENG; Yang C.-H.
臺大學術典藏	2021-09-01T01:54:17Z	Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma	Hsu C.-H.; Shen Y.-C.; Lin Z.-Z.; Chen P.-J.; Shao Y.-Y.; Ding Y.-H.; Hsu C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:16Z	Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation	Chen K.-F.; Yu H.-C.; Liu T.-H.; Lee S.-S.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:16Z	Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma	Hsu C.-H.; Yang T.-S.; Hsu C.; Toh H.C.; Epstein R.J.; Hsiao L.-T.; Chen P.-J.; Lin Z.-Z.; Chao T.-Y.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:16Z	Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin	Shao Y.-Y.; Kuo K.-T.; Hu F.-C.; Lu Y.-S.; Huang C.-S.; Liau J.-Y.; Lee W.-C.; Hsu C.; Kuo W.-H.; Chang K.-J.; Lin C.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:16Z	Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma	Omata M.; Lesmana L.A.; Tateishi R.; Chen P.-J.; Lin S.-M.; Yoshida H.; Kudo M.; Lee J.M.; Choi B.I.; Poon R.T.P.; Shiina S.; ANN-LII CHENG; Jia J.-D.; Obi S.; Han K.H.; Jafri W.; Chow P.; Lim S.G.; Chawla Y.K.; Budihusodo U.; Gani R.A.; Lesmana C.R.; Putranto T.A.; Liaw Y.F.; Sarin S.K.
臺大學術典藏	2021-09-01T01:54:15Z	Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach	Shen Y.-C.; Hsu C.; Chen L.-T.; Cheng C.-C.; Hu F.-C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:15Z	Unusual presentation of multiple pathologic bone fractures in a patient with gastric mucosa-associated lymphoid tissue lymphoma	Kuo S.-H.; Yen R.-F.; Lin C.-W.; Chen L.-T.; Tien H.F.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:15Z	The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells	Yan K.-H.; Yao C.-J.; Chang H.-Y.; Lai G.-M.; ANN-LII CHENG; Chuang S.-E.
臺大學術典藏	2021-09-01T01:54:14Z	Vinorelbine plus 24-hour infusion of high-dose 5-fluorouracil and leucovorin as effective palliative chemotherapy for breast cancer patients with acute disseminated intravascular coagulation	Lin P.-H.; Lu Y.-S.; Lin C.-H.; Chang D.-Y.; Huang C.-S.; ANN-LII CHENG; Yeh K.-H.
臺大學術典藏	2021-09-01T01:54:14Z	Clinical Development and Future Direction for the Treatment of Hepatocellular Carcinoma	Whang-Peng J.; ANN-LII CHENG; Hsu C.; Chen C.-M.
臺大學術典藏	2021-09-01T01:54:14Z	O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers	Wu P.-F.; Kuo K.-T.; Kuo L.-T.; Lin Y.-T.; Lee W.-C.; Lu Y.-S.; Yang C.-H.; Wu R.-M.; Tu Y.-K.; Tasi J.-C.; Tseng H.-M.; Tseng S.-H.; ANN-LII CHENG; Lin C.-H.
臺大學術典藏	2021-09-01T01:54:13Z	Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells	Weng Y.-I.; Hsu P.-Y.; Liyanarachchi S.; Liu J.; Deatherage D.E.; Huang Y.-W.; Zuo T.; Rodriguez B.; Lin C.-H.; ANN-LII CHENG; Huang T.H.-M.
臺大學術典藏	2021-09-01T01:54:13Z	Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC	Lin Z.-Z.; Jeng Y.-M.; Hu F.-C.; Pan H.-W.; Tsao H.-W.; Lai P.; Lee P.; ANN-LII CHENG; Hsu H.-C.
臺大學術典藏	2021-09-01T01:54:13Z	Liver cancer working group report	Kudo M.; Han K.H.; Kokudo N.; ANN-LII CHENG; Choi B.I.; Furuse J.; Izumi N.; Park J.-W.; Poon R.T.; Sakamoto M.
臺大學術典藏	2021-09-01T01:54:13Z	Translocation of Helicobacter pylori CagA into human B lymphocytes, the origin of mucosa-associated lymphoid tissue lymphoma	Lin W.-C.; Tsai H.-F.; Kuo S.-H.; Wu M.-S.; Lin C.-W.; Hsu P.-I.; ANN-LII CHENG; Hsu P.-N.
臺大學術典藏	2021-09-01T01:54:12Z	Induction of DNA damage-inducible gene GADD45β contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cells	Ou D.-L.; Shen Y.-C.; Yu S.-L.; Chen K.-F.; Yeh P.-Y.; Fan H.-H.; Feng W.-C.; Wang C.-T.; Lin L.-I.; Hsu C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:12Z	E2A-positive gastric MALT lymphoma has weaker plasmacytoid infiltrates and stronger expression of the memory B-cell-associated miR-223: Possible correlation with stage and treatment response	Liu T.-Y.; Chen S.-U.; Kuo S.-H.; ANN-LII CHENG; Lin C.-W.
臺大學術典藏	2021-09-01T01:54:12Z	Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma	Shao Y.-Y.; Lin Z.-Z.; Hsu C.; Shen Y.-C.; Hsu C.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:12Z	Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3	Chen K.-F.; Tai W.-T.; Liu T.-H.; Huang H.-P.; Lin Y.-C.; Shiau C.-W.; Li P.-K.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:11Z	Recent advances in the treatment of metastatic colorectal cancer in Taiwan	Lin Y.-L.; Yeh K.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:11Z	Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma	Chiang C.-T.; Yeh P.-Y.; Gao M.; Chen C.-W.; Yeh L.-C.; Feng W.-C.; Kuo S.-H.; Hsu C.-H.; Lu Y.-S.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:11Z	CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells	Chen K.-F.; Liu C.-Y.; Lin Y.-C.; Yu H.-C.; Liu T.-H.; Hou D.-R.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:10Z	Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinoma	Shao Y.U.-Y.; Chen P.-J.; Lin Z.-Z.; Huang C.-C.; Ding Y.-H.; Lee Y.-H.; Hsu C.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:10Z	Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A	Chen K.-F.; Yu H.-C.; Liu C.-Y.; Chen H.-J.; Chen Y.-C.; Hou D.-R.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:10Z	Needs for hepatocellular carcinoma control policy in the Asia-Pacific region	Bridges J.F.P.; Joy S..; Gallego G.; Kudo M.; Ye S.-L.; Han K.-H.; ANN-LII CHENG; Blauvelt B.
臺大學術典藏	2021-09-01T01:54:10Z	Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf	Chen K.-F.; Tai W.-T.; Huang J.-W.; Hsu C.-Y.; Chen W.-L.; ANN-LII CHENG; Chen P.-J.; Shiau C.-W.
臺大學術典藏	2021-09-01T01:54:10Z	Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells	Chen K.-F.; Chen H.-L.; Tai W.-T.; Feng W.-C.; Hsu C.-H.; Chen P.-J.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:09Z	Phase I, pharmacokinetic, and bone marrow drug-level studies of trimonthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers	Ho Y.-F.; Lu W.-C.; Chen R.R.-L.; ANN-LII CHENG; Yeh K.-H.
臺大學術典藏	2021-09-01T01:54:09Z	Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma	Tai W.-T.; ANN-LII CHENG; Shiau C.-W.; Huang H.-P.; Huang J.-W.; Chen P.-J.; Chen K.-F.
臺大學術典藏	2021-09-01T01:54:09Z	Increasing incidence of brain metastasis in patients with advanced Hepatocellular carcinoma in the era of Antiangiogenic targeted therapy	Shao Y.-Y.; Lu L.-C.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏	2021-09-01T01:54:08Z	A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan	Chen J.-S.; Chao Y.; Hsieh R.-K.; ANN-LII CHENG; Chen P.-M.; Chiou T.-J.; Chao T.-Y.; Yeh K.-H.; Chen L.-T.; Whang-Peng J.
臺大學術典藏	2021-09-01T01:54:08Z	Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells	Rodriguez B.A.T.; Weng Y.-I.; Liu T.-M.; Zuo T.; Hsu P.-Y.; Lin C.-H.; ANN-LII CHENG; Cui H.; Yan P.S.; Huang T.H.-M.
臺大學術典藏	2021-09-01T01:54:08Z	IκB kinases increase Myc protein stability and enhance progression of breast cancer cells	Yeh P.-Y.; Lu Y.-S.; Ou D.-L.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:08Z	Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001	Kuo S.-H.; Hsu C.-H.; Chen L.-T.; Lu Y.-S.; Lin C.-H.; Yeh P.-Y.; Jeng H.-J.; Gao M.; Yeh K.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T01:54:07Z	Prognostic molecular markers in Women aged 35 years or younger with breast cancer: Is there a difference from the older patients?	Lin C.-H.; Lu Y.-S.; Huang C.-S.; Kuo K.-T.; Wang C.-C.; You S.-L.; Lin P.-H.; Chang D.-Y.; Kuo W.-H.; Chang K.-J.; ANN-LII CHENG

显示项目 231-280 / 690 (共14页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 51169487 在线人数 : 645 教育部委托研究计画计画执行:国立台湾大学图书馆